IL114271A - Oxophthalazinic acid derivatives Acetic acid - Google Patents
Oxophthalazinic acid derivatives Acetic acidInfo
- Publication number
- IL114271A IL114271A IL114271A IL11427190A IL114271A IL 114271 A IL114271 A IL 114271A IL 114271 A IL114271 A IL 114271A IL 11427190 A IL11427190 A IL 11427190A IL 114271 A IL114271 A IL 114271A
- Authority
- IL
- Israel
- Prior art keywords
- oxo
- compound
- oxophthalazinyl
- solution
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,997 US4954629A (en) | 1989-05-11 | 1989-05-11 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL114271A true IL114271A (en) | 1998-04-05 |
Family
ID=23379152
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
IL114271A IL114271A (en) | 1989-05-11 | 1990-05-06 | Oxophthalazinic acid derivatives Acetic acid |
IL11427195A IL114271A0 (en) | 1989-05-11 | 1995-06-22 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9430190A IL94301A (en) | 1989-05-11 | 1990-05-06 | Process for the preparation of acetic oxophetylazinyl acids, certain new compounds and pharmaceutical preparations containing them |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11427195A IL114271A0 (en) | 1989-05-11 | 1995-06-22 | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
Country Status (30)
Country | Link |
---|---|
US (1) | US4954629A (es) |
EP (1) | EP0397350B1 (es) |
JP (1) | JPH035479A (es) |
KR (1) | KR920006419B1 (es) |
CN (1) | CN1025855C (es) |
AR (1) | AR246968A1 (es) |
AT (1) | ATE103913T1 (es) |
AU (2) | AU618898B2 (es) |
BG (1) | BG50609A3 (es) |
CA (1) | CA2016504C (es) |
CZ (1) | CZ281213B6 (es) |
DD (1) | DD294257A5 (es) |
DE (1) | DE69007846T2 (es) |
DK (1) | DK0397350T3 (es) |
EG (1) | EG19082A (es) |
ES (1) | ES2063265T3 (es) |
FI (1) | FI93959C (es) |
HU (1) | HU212304B (es) |
IE (1) | IE62591B1 (es) |
IL (3) | IL94301A (es) |
MX (2) | MX167455B (es) |
NO (1) | NO177708C (es) |
NZ (1) | NZ233597A (es) |
PH (1) | PH26567A (es) |
PL (1) | PL164427B1 (es) |
PT (1) | PT93985B (es) |
RO (1) | RO107256B1 (es) |
RU (1) | RU2014333C1 (es) |
YU (1) | YU91290A (es) |
ZA (1) | ZA903565B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
IL124236A (en) * | 1997-05-05 | 2003-01-12 | Pfizer | Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor |
EP0982306A3 (en) * | 1998-08-21 | 2000-07-05 | Pfizer Products Inc. | Polymorph of zopolrestat monohydrate |
JP5934206B2 (ja) * | 2010-07-16 | 2016-06-15 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | アルドース還元酵素阻害剤および同使用方法 |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
CN102558184B (zh) * | 2011-12-30 | 2014-07-16 | 西南大学 | 酞嗪类衍生物的合成方法 |
CN102702108A (zh) * | 2012-06-27 | 2012-10-03 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
CN102863393A (zh) * | 2012-09-26 | 2013-01-09 | 上海大学 | 1,2-二氢酞嗪类化合物及其合成方法 |
BR112018076244A2 (pt) | 2016-06-21 | 2019-03-26 | The Trustees Of Columbia University In The City Of New York | inibidores da aldose redutase e métodos de uso destes |
PL3658142T3 (pl) | 2017-07-28 | 2024-08-26 | Applied Therapeutics, Inc. | Związki i sposoby leczenia galaktozemii |
JP2022519944A (ja) | 2019-04-01 | 2022-03-25 | アプライド セラピューティクス インコーポレイテッド | アルドースレダクターゼの阻害剤 |
SG11202111822QA (en) | 2019-05-07 | 2021-11-29 | Univ Miami | Treatment and detection of inherited neuropathies and associated disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
DE3337859A1 (de) * | 1983-01-21 | 1984-07-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzthiazolen |
ES2032749T3 (es) * | 1985-11-07 | 1993-03-01 | Pfizer Inc. | Acidos oxoftalazinil-aceticos heterociclicos. |
CA1299178C (en) * | 1985-11-07 | 1992-04-21 | Banavara Lakshmana Mylari | Heterocyclic oxophtalazinyl acetic acids |
JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
EP0322153A3 (en) * | 1987-12-21 | 1990-08-16 | Pfizer Inc. | Heterocyclic oxophtalazinyl acetic acids |
WO1989006651A1 (en) * | 1988-01-19 | 1989-07-27 | Pfizer Inc. | 1h-indazole-3-acetic acids as aldose reductase inhibitors |
US4996204A (en) * | 1989-05-11 | 1991-02-26 | Pfizer Inc. | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
-
1989
- 1989-05-11 US US07/350,997 patent/US4954629A/en not_active Expired - Lifetime
-
1990
- 1990-04-25 AT AT90304441T patent/ATE103913T1/de not_active IP Right Cessation
- 1990-04-25 DK DK90304441.0T patent/DK0397350T3/da active
- 1990-04-25 EP EP90304441A patent/EP0397350B1/en not_active Expired - Lifetime
- 1990-04-25 ES ES90304441T patent/ES2063265T3/es not_active Expired - Lifetime
- 1990-04-25 DE DE69007846T patent/DE69007846T2/de not_active Expired - Fee Related
- 1990-05-02 RO RO144965A patent/RO107256B1/ro unknown
- 1990-05-04 IE IE162690A patent/IE62591B1/en not_active IP Right Cessation
- 1990-05-06 IL IL9430190A patent/IL94301A/en not_active IP Right Cessation
- 1990-05-06 IL IL114271A patent/IL114271A/en not_active IP Right Cessation
- 1990-05-08 CZ CS902278A patent/CZ281213B6/cs not_active IP Right Cessation
- 1990-05-08 NZ NZ233597A patent/NZ233597A/en unknown
- 1990-05-09 PT PT93985A patent/PT93985B/pt not_active IP Right Cessation
- 1990-05-09 PL PL90285113A patent/PL164427B1/pl unknown
- 1990-05-10 FI FI902333A patent/FI93959C/fi not_active IP Right Cessation
- 1990-05-10 CA CA002016504A patent/CA2016504C/en not_active Expired - Fee Related
- 1990-05-10 RU SU904743977A patent/RU2014333C1/ru active
- 1990-05-10 NO NO902071A patent/NO177708C/no not_active IP Right Cessation
- 1990-05-10 AR AR90316824A patent/AR246968A1/es active
- 1990-05-10 BG BG091982A patent/BG50609A3/xx unknown
- 1990-05-10 YU YU91290A patent/YU91290A/sh unknown
- 1990-05-10 CN CN90102797A patent/CN1025855C/zh not_active Expired - Fee Related
- 1990-05-10 HU HU902995A patent/HU212304B/hu not_active IP Right Cessation
- 1990-05-10 AU AU54906/90A patent/AU618898B2/en not_active Ceased
- 1990-05-10 DD DD90340590A patent/DD294257A5/de not_active IP Right Cessation
- 1990-05-10 ZA ZA903565A patent/ZA903565B/xx unknown
- 1990-05-10 KR KR1019900006579A patent/KR920006419B1/ko not_active IP Right Cessation
- 1990-05-10 EG EG27690A patent/EG19082A/xx active
- 1990-05-11 MX MX020672A patent/MX167455B/es unknown
- 1990-05-11 JP JP2122862A patent/JPH035479A/ja active Granted
- 1990-05-11 PH PH40512A patent/PH26567A/en unknown
-
1991
- 1991-10-28 AU AU86806/91A patent/AU626225B2/en not_active Ceased
-
1992
- 1992-12-31 MX MX9207687A patent/MX9207687A/es not_active IP Right Cessation
-
1995
- 1995-06-22 IL IL11427195A patent/IL114271A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1176269A (en) | N-naphthoylglycine derivatives | |
EP0397350B1 (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
CA2562244A1 (en) | Cyclic compounds | |
CA1248532A (en) | Pyrazolo¬3,4-b|pyridine derivatives and process for producing them | |
EP0011142B1 (de) | Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate | |
JPH06116264A (ja) | ジヒドロイミダゾピロロピリジン類及びそれらの誘導体 | |
CA1306747C (en) | Process for the preparation of new heterocyclic derivatives which can be used especially as aldose reductase inhibitors | |
JPH0660163B2 (ja) | 置換オキソフタラジニル酢酸およびその同族体 | |
CZ386892A3 (en) | Novel 2-saccharinylmethyl heterocyclic carboxylates usable as proteolytic enzymes inhibitors and their compositions and method of application | |
US5017581A (en) | Pyridonecarboxylic acids and their anti-bacterial compositions | |
US5171862A (en) | Process and indazole intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
US5075442A (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
US5182391A (en) | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof | |
Silva et al. | Synthesis and structural elucidation of new benzylidene imidazolidines and acridinylidene thiazolidines | |
KR920007497B1 (ko) | Lo/co 억제 벤즈옥사졸론 | |
RU2095359C1 (ru) | Производные имидазолина и способ их получения | |
SK70798A3 (en) | Process for preparing dioxoazabicyclohexanes | |
NO179004B (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater | |
US4307092A (en) | 1-Oxo-5H-pyrimido[2,1-C]benzoxazine-2-carboxylic acid esters | |
Nesi et al. | A new spiro annellation reaction in the isoxazole series: applications and limits. Part 2. Reactivity of ethyl 4-nitro-3-phenylisoxazole-5-carboxylate with nitrogen binucleophiles | |
JPS63218662A (ja) | ハロゲンシクロプロピル−化合物、その製造および化合物を含有する除草剤 | |
CN115160285A (zh) | 硫代酰胺类aldh2激动剂、制备方法及应用 | |
EP0568540A1 (en) | 2,4-DIOXO-PYRIDO 2,3-d]PYRIMIDINE-3-ACETIC ACIDS AND ESTERS AND SALTS THEREOF | |
FR2669928A1 (fr) | Nouveaux derives de pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |